News | News By Subject | News by Disease News By Date | Search News

Cancer (misc) News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Sanofi (SNY) and Regeneron (REGN) Ink $2.2 Billion Immuno-Oncology, PD-1 Inhibitor Deal     7/28/2015
Partnership and Acquisition Rumors in the CAR-T Cancer Space Finger Juno (JUNO), Kite Pharma (KITE) and bluebird bio (BLUE)     7/20/2015
NantBioscience, Sorrento Form $100 Million JV to Develop Moonshot Cancer Program     7/10/2015
EXCLUSIVE: Pediatric Patients Could Benefit Most From New Oncoceutics Cancer Drug, Says Exec     7/2/2015
Juno Therapeutics (JUNO) Stock Soars After Celgene (CELG) Acquires $1 Billion Stake in Seattle Company     6/30/2015
EXCLUSIVE: Cellular Biomedicine Group (CBMG) Ready to Hire After Snapping Up Cancer Vaccine     6/26/2015
Aquinox (AQXP)’s Bladder Pain Drug Fails to Meet Statistical Endpoint in Phase II Trial     6/25/2015
Epizyme (EPZM) Surges on NHL Cancer Drug Data, As Analysts Laud Early Successes     6/24/2015
Kite Pharma (KITE), bluebird bio (BLUE) Ink Deal to Zero In on HPV-Linked Cancer     6/22/2015
Almac Discovery Wrangles R&D Deal Worth $363.5 Million+ From Genentech (RHHBY)     6/16/2015
MIT Phenom's Science Cranks Out Another Startup XTuit Pharma     6/11/2015
Celgene (CELG) Shells Out $82.5 Million in Cash for Portfolio, Option to Buy Lycera     6/9/2015
ASCO15: Amgen (AMGN) Was "Quiet Winner" at Cancer Conference, Says Analyst     6/8/2015
AstraZeneca PLC (AZN)'s Booming Immuno-Onco Pipeline Validates Rebuffing Pfizer (PFE)     6/5/2015
Celgene (CELG) Will Focus On Anti-BCMA Drug, As It Returns CAR-T Pack to bluebird bio (BLUE)     6/5/2015

News from Around the Web
"Pill On A String" Could Help Spot Early Signs Of Cancer Of The Gullet, University of Cambridge Study     7/27/2015
The Environmental Influence On Epigenetics, National Institute of Environmental Health Sciences Study     7/24/2015
NanoString (NSTG) CEO On How Creating A Niche Is Good For Business: Q&A     7/23/2015
DNA Damage Seen In Patients Undergoing CT Scanning, Stanford University School of Medicine Reveals     7/23/2015
Red Wine Oxidant Could Provide New Options For Cancer Therapy, Oregon State University Study     7/17/2015
Too Much Sitting May Boost Women's Cancer Risk, Mount Sinai School of Medicine Study     7/17/2015
6 Little-Known Facts About Oral Sex     7/17/2015
New Cell Structure Discovery Could Help Scientists Understand Cancer Better, University of Warwick Study     7/15/2015
Glasses That Make Cancer Glow, Washington University Study     7/15/2015
Blood Test That Detects Genetic Disorders In Fetuses Could Help In Mom’s Early Cancer Diagnosis     7/15/2015
Photoacoustic Approach To Breast Cancer Detection, University of Twente Study     7/14/2015
Unwanted Side Effects Of Cannabis Isolated, University of East Anglia Reveals     7/10/2015
Breath Analysis By Laser "Could One Day Screen For Diabetes, Cancer," University of Adelaide Study     7/8/2015
Living Cells Levitate In Possible Cancer Detection Breakthrough, Stanford University Reveals     7/1/2015
Compound In Magnolia May Combat Head And Neck Cancers, University of Alabama at Birmingham Study     6/29/2015

Press Releases
University of Colorado Cancer Center And Loxo Oncology (LOXO) Announce Publication That Provides Clinical Validation For LOXO-101 Against TRK Fusion Cancer     7/28/2015
OncoMed Pharmaceuticals, Inc. (OMED) Initiates Phase I Clinical Trial For Anti-RSPO3 Antibody     7/28/2015
ISA Pharmaceuticals Release: Towards A Best Practice Approach In Cancer Immunotherapy: Cancer Vaccines Gain Momentum     7/28/2015
AEterna Zentaris (AEZS) Grants Option To Develop And Commercialize Oral Allogenic Cancer Vaccine Technology     7/28/2015
TapImmune Inc. (TPIV) Announces Finalization Of License Agreement With Mayo Clinic To Commercialize A Folate Receptor Alpha Vaccine For Multiple Cancer Indications     7/27/2015
Horizon Pharma (HZNP) Announces Collaboration With Fox Chase Cancer Center To Study ACTIMMUNE (Interferon Gamma-1b) In Combination With PD-1/PD-L1 Inhibitors In Various Forms Of Cancer     7/27/2015
Navidea (NAVB) Release: Verification Of Lymphoseek Mechanism Of Action Published In Journal Of Immunology     7/23/2015
PharmaMar S.A. Announces License Agreement With TTY Biopharm For APLIDIN (plitidepsin) In Hematological Cancers     7/23/2015
Adaptimmune’s NY-ESO-1 TCR-Engineered T-Cells Demonstrate Durable Persistence, Clinical Activity And Tolerability In Clinical Study In Multiple Myeloma Patients     7/20/2015
Fox Chase Cancer Center To Conduct ONC201 Dose Intensification Trial     7/20/2015
Novonco Pharma Teams With City of Hope To Build Better Cancer Drug     7/20/2015
NeoGenomics, Inc. (NGNM.OB) Launches Germline Cancer Predisposition Testing     7/20/2015
Novogen Limited (NVGN) Release: Pre-clinical Studies Suggest Anisina May Improve Chemotherapy Effectiveness In Childhood Cancer     7/14/2015
Blaze Bioscience Inc. Announces Open Enrollment For Phase 1 Clinical Trial Of Tumor Paint BLZ-100 In Patients With Solid Tumor Cancers     7/14/2015
Oncoceutics Announces Completion Of ONC201 First-in-Man Study     7/13/2015